Glaxosmithkline
GlaxoSmithKline plc (GSK), a leading global healthcare company headquartered in Great Britain, has been at the forefront of pharmaceutical innovation since its founding in 2000, following the merger of Glaxo Wellcome and SmithKline Beecham. With a strong presence in Europe, North America, and emerging markets, GSK operates primarily in the pharmaceutical, vaccine, and consumer healthcare sectors. The company is renowned for its diverse portfolio, which includes groundbreaking medicines, vaccines, and consumer health products that address a wide range of health needs. GSK's commitment to research and development has led to significant advancements in areas such as respiratory diseases, HIV, and immunology. As a key player in the global healthcare landscape, GSK continues to achieve notable milestones, reinforcing its position as a trusted provider of innovative health solutions.
DitchCarbon Score
How does Glaxosmithkline's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Glaxosmithkline's score of 96 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Glaxosmithkline's reported carbon emissions
In 2023, GlaxoSmithKline (GSK) reported total greenhouse gas emissions of approximately 581,000,000 kg CO2e for Scope 1, 64,000,000 kg CO2e for Scope 2, and 8,983,000 kg CO2e for Scope 3 emissions. This reflects GSK's ongoing commitment to reducing its carbon footprint across all scopes of emissions. GSK has set ambitious targets to address its greenhouse gas emissions. The company aims to reduce absolute Scope 1 and 2 emissions by 80% by 2030 from a 2020 base year, and to achieve net-zero emissions across its value chain by 2045. Additionally, GSK is committed to reducing absolute Scope 3 emissions by 80% within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to keep global warming below 1.5°C. In previous years, GSK's emissions were significantly higher, with Scope 1 emissions reaching about 892,000,000 kg CO2e in 2017 and Scope 2 emissions at approximately 694,000,000 kg CO2e. The company has made substantial progress in reducing its emissions, demonstrating a commitment to sustainability and environmental responsibility. GSK's long-term strategy includes a further reduction of absolute Scope 1 and 2 emissions by 90% by 2045, alongside a similar reduction for Scope 3 emissions. This comprehensive approach underscores GSK's dedication to combating climate change and promoting a sustainable future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 851,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 745,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 16,093,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000 | 0,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Glaxosmithkline is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
